Physician profile
Floyd John Herman
NPI 1730416553
$10,907.60
in general payments reported to CMS, 2019-2025
24 companies · $720 in 2025
The $720 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,731 · 2020: $6,953 · 2021: $159 · 2022: $404 · 2023: $239 · 2024: $701 · 2025: $720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,633 · Consulting Fee: $27.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,633.13 |
| Consulting Fee | $27.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $6,546.33 | 2020 | |
| Axogen | $1,395.71 | 2019 | |
| Smith+Nephew, INC. | $1,056.90 | 2019-2025 | Grafix Pl, Collagenase Santyl, Acticoat 4" X 4" |
| Organogenesis INC. | $605.97 | 2019-2025 | Puraply Wound Matrix |
| Mimedx Group, INC. | $405.16 | 2025 | |
| Reddress USA, INC. | $126.96 | 2024 | |
| Hartmann USA, INC. | $120.46 | 2024 | Zetuvit Plus 10x10 P10 |
| Aroa Biosurgery Incorporated | $99.21 | 2019-2020 | |
| Kerecis Limited | $91.06 | 2022 | |
| Tela Bio, INC. | $75.91 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Bioventus LLC | $61.78 | 2022 | |
| Kci USA, INC. | $48.28 | 2020-2022 | |
| Solventum Corporation | $42.72 | 2024-2025 | Activ.A.C. |
| Misonix INC | $33.68 | 2019-2021 | |
| Integra Lifesciences Corporation | $33.11 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $29.10 | 2019-2023 | Xiaflex |
| Next Science LLC | $27.55 | 2024 | Surgx, Xperience, Blastx |
| Motiva USA, LLC | $18.96 | 2025 | |
| Baxter Healthcare | $18.42 | 2024 | |
| Lifenet Health | $17.85 | 2025 | Theragenesis Wound Matrix |
| Urgo Medical North America, LLC | $17.33 | 2025 | Urgok2 |
| Ovik Health, LLC | $15.11 | 2024 | Coflex Tlc |
| Acell, INC. | $10.38 | 2020 | |
| Cashflow Solutions, LLC | $9.66 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Floyd Herman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.